Product NDC: | 63323-280 |
Proprietary Name: | Furosemide |
Non Proprietary Name: | FUROSEMIDE |
Active Ingredient(s): | 10 mg/mL & nbsp; FUROSEMIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-280 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018902 |
Marketing Category: | NDA |
Start Marketing Date: | 20000712 |
Package NDC: | 63323-280-04 |
Package Description: | 25 VIAL in 1 TRAY (63323-280-04) > 4 mL in 1 VIAL |
NDC Code | 63323-280-04 |
Proprietary Name | Furosemide |
Package Description | 25 VIAL in 1 TRAY (63323-280-04) > 4 mL in 1 VIAL |
Product NDC | 63323-280 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FUROSEMIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20000712 |
Marketing Category Name | NDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | FUROSEMIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |